Table 4. Correlations of baseline carotid artery compliance and change in compliance with ascorbic acid with participant characteristics.
Baseline compliance | Change in compliance | |||
---|---|---|---|---|
|
|
|||
Participant characteristic | Correlation coefficient | P | Correlation coefficient | P |
Age | −0.72 | <0.001 | 0.12 | 0.23 |
Time since menopause | −0.23 | 0.21 | 0.34 | 0.07 |
Body mass | −0.21 | 0.04 | −0.04 | 0.70 |
BMI | −0.35 | <0.001 | −0.01 | 0.96 |
Total body fat | −0.50 | <0.001 | 0.23 | 0.02 |
Trunk fat | −0.49 | <0.001 | 0.23 | 0.02 |
Waist circumference | −0.29 | 0.007 | 0.04 | 0.70 |
WHR | −0.20 | 0.07 | 0.06 | 0.56 |
VO2max | 0.56 | <0.001 | −0.1 | 0.35 |
LTPA | 0.20 | 0.06 | −0.14 | 0.19 |
Seated SBP | −0.40 | <0.001 | −0.09 | 0.40 |
Seated DBP | −0.21 | 0.04 | −0.10 | 0.32 |
Total cholesterol | −0.40 | <0.001 | 0.02 | 0.84 |
LDL cholesterol | −0.69 | <0.001 | 0.04 | 0.71 |
HDL cholesterol | 0.04 | 0.67 | −0.05 | 0.63 |
Triglycerides | −0.27 | 0.009 | 0.07 | 0.48 |
Fasting insulin | −0.09 | 0.39 | 0.03 | 0.76 |
Fasting glucose | −0.13 | 0.21 | 0.02 | 0.82 |
FSH | −0.44 | <0.001 | 0.16 | 0.13 |
Estradiol | 0.36 | <0.001 | −0.14 | 0.17 |
Progesterone | 0.26 | 0.01 | −0.36 | <0.001 |
Estrone | 0.26 | 0.01 | −0.20 | 0.05 |
SHBG | 0.06 | 0.54 | −0.08 | 0.45 |
Testosterone | 0.18 | 0.08 | −0.07 | 0.48 |
DHEAS | 0.49 | <0.001 | −0.16 | 0.13 |
Oxidized LDL | −0.30 | 0.003 | −0.13 | 0.19 |
TAS | 0.10 | 0.35 | −0.14 | 0.17 |
Glutathione peroxidase | −0.02 | 0.87 | 0.07 | 0.51 |
Norepinephrine | −0.23 | 0.03 | −0.03 | 0.76 |
Endothelin-1 | −0.09 | 0.41 | 0.20 | 0.06 |
IL-6 | −0.21 | 0.04 | 0.17 | 0.11 |
CRP | −0.32 | 0.001 | 0.02 | 0.84 |
Carotid IMT | −0.46 | <0.001 | −0.10 | 0.31 |
BMI, body mass index; WHR, waist-to-hip ratio; VO2max, maximal aerobic power; LTPA, leisure time physical activity; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; FSH, follicle-stimulating hormone; SHBG, sex hormone–binding globulin; DHEAS, dehydroepiandrosterone sulfate; TAS, total antioxidant status; IL, interleukin; CRP, C-reactive protein; IMT, intima-media thickness.